Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
This study has been terminated.
( See termination reason in detailed description. )
Study NCT00452842   Information provided by Pfizer

First Received on March 26, 2007.   Last Updated on February 21, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Disease
Cerebrovascular Disorders
Additional conditions recognized in this trial
Cardiovascular Diseases
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Atorvastatin
Torcetrapib
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services